4.500USD-1.42%Mkt Cap: 885.96M USDP/E: 5.40Last update: 2026-06-01
Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline comprises Imdusiran, conj…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap885.96M USD
Enterprise Value809.45M USD
Revenue (TTM)191.44M USD
Gross Profit171.04M USD
Net Income (TTM)-33.50M USD
Revenue/Share0.9950 USD
Last Price4.500 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees19
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINCA03879J1003
Valuation
P/E (Trailing)5.40
P/E (Forward)-27.59
PEG—
EV/EBITDA5.22
EV/Revenue4.23
P/S4.71
P/B3.45
EPS (TTM)0.83
EPS (Forward)-0.17
52W Range
3.04071% of range5.100
52W High5.100 USD
52W Low3.040 USD
Profitability
Gross Margin89.34%
Oper. Margin94.41%
EBITDA Margin81.04%
Profit Margin-237.88%
ROE-43.75%
ROA-35.41%
Growth
Revenue Growth10054.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-39.64M USD
CapEx (TTM)—
FCF Margin-47.22%
FCF Yield-10.20%
Net Debt-91.32M USD
Net Debt/EBITDA-0.59
Balance Sheet
Debt/Equity0.01
Current Ratio54.26
Quick Ratio54.00
Book Value/Sh1.321 USD
Cash/Share0.4820 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:5
Split DateNov 4, 2010
Analyst Consensus
Rating—
Target (Mean)5.150 USD
Target Range4.954 USD – 5.476 USD
# Analysts3
Ownership
Shares Out.197.54M
Float121.37M
Insiders20.46%
Institutions71.91%
Short Interest
Short Ratio9.1d
Short % Float12.38%
Short % Out.8.32%
Shares Short16.44M
Short (prev mo.)17.80M
Technical
SMA 504.378 (+2.8%)
SMA 2004.352 (+3.4%)
Beta0.62
S&P 52W Chg27.94%
Avg Vol (30d)1.62M
Avg Vol (10d)1.68M
Technical Indicators
RSI (14)57.9
MACD0.0507
MACD Signal0.0128
MACD Hist.+0.0379
BB Upper4.639 USD
BB Middle4.386 USD
BB Lower4.133 USD
BB Width11.53%
ATR (14)0.1859 USD
Vol Ratio (20d)1.14x